Keyphrases
Heart Transplantation
95%
Cardiac Allograft Vasculopathy
44%
Heart Transplant Recipients
42%
Intravascular Ultrasound
28%
Cardiomyopathy
28%
Liver Transplantation
28%
Left Ventricular Ejection Fraction
18%
Heart Transplant
18%
Acute Cellular Rejection
17%
Post-transplant Outcomes
16%
Everolimus
16%
Cardiac Amyloid
16%
Steroid Withdrawal
14%
Immunosuppressive Regimens
14%
Panel-reactive Antibody
14%
Serial Measurements
14%
Human Leukocyte Antigen Antibodies
14%
Continuous Flow System
14%
Right Atrial Pressure
14%
Coronary Angiography
14%
Tricuspid Annular Plane Systolic Excursion (TAPSE)
14%
Cell Development
14%
Calcineurin Inhibitors
14%
Glomerular Filtration Rate
14%
Graft Function
14%
Prognostic Value
14%
Rubidium
14%
Guide Selection
14%
Albuminuria
14%
Ultrasound-guided
14%
Myocardial Flow Reserve
14%
Positron Emission Tomography
14%
Transthyretin Amyloidosis
14%
Cardiac Allograft
14%
Flow Effect
14%
Corticosteroid Withdrawal
14%
Mechanical Circulatory Support
14%
Complement Activation
14%
Immunoglobulin Light Chain Amyloidosis
14%
Left Ventricular Assist Device Implantation
14%
Corticosteroids
14%
Transplantation
13%
Amyloidosis
12%
Invasive Coronary Angiography
12%
Ventricular Assist Device
11%
Treatment Options
10%
End-stage Heart Failure
9%
Median Survival
9%
Intimal Thickness
8%
Between-group
7%
Medicine and Dentistry
Heart Transplantation
100%
Heart Graft
57%
Cardiac Allograft Vasculopathy
53%
Acute Graft Rejection
37%
Intravascular Ultrasound
28%
Cardiomyopathy
28%
Liver Transplantation
28%
Transplantation
27%
Coronary Angiography
26%
Heart Left Ventricle Ejection Fraction
21%
Amyloid
19%
Assisted Circulation
18%
Everolimus
16%
ATTR Amyloidosis
14%
Positron Emission Tomography
14%
Adverse Event
14%
Heart Right Atrium Pressure
14%
Coronary Circulation
14%
Calcineurin Inhibitor
14%
Complement Activation
14%
Rubidium 82
14%
Chronic Kidney Disease
14%
Glomerular Filtration Rate
14%
Albuminuria
14%
AL Amyloidosis
14%
Immunosuppressive Drug
14%
Left Ventricular Assist Device
14%
Allograft
14%
Amyloidosis
14%
Transthyretin
12%
Immunosuppressive Treatment
11%
Heart Failure
11%
Overall Survival
10%
Graft Dysfunction
10%
Creatinine
8%
Hyperlipidemia
7%
Osteoporosis
7%
Diabetes
7%
Complement Component C4d
6%
All Cause Mortality
6%
Kaplan Meier Method
6%
Survival Rate
6%
Heart Function
6%
Neuropathy
5%
Heart Muscle Biopsy
5%